Vascular failure: a new clinical entity for vascular disease
- 1 November 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 24 (11) , 2121-2130
- https://doi.org/10.1097/01.hjh.0000249684.76296.4f
Abstract
Atherosclerosis is characterized by the response of the vessel wall to chronic multifactorial injury leading to the formation of atheromatous or fibrous plaques. Endothelial dysfunction represents an initial stage of atherosclerosis. In addition to endothelial dysfunction, smooth muscle dysfunction, metabolic abnormalities of the vessel wall including inflammation, oxidative stress and alterations of neurohormonal balance occur in various stages of atherosclerosis. We now propose a new clinical entity ‘vascular failure’, defined as the integration of all of these vascular abnormalities. Vascular failure is not an anatomical disease, but rather a comprehensive syndrome of abnormal vascular function. Vascular failure extends from risk factors to established atherosclerotic disease with arterial stenosis, and further to calcification of the vessel wall or serious vascular events that may be caused by plaque rupture and thromboembolic occlusion. We propose aggressive intervention to modify various risk factors, applying to this integrated new entity, vascular failure.Keywords
This publication has 76 references indexed in Scilit:
- A single dose of nateglinide improves post‐challenge glucose metabolism and endothelial dysfunction in Type 2 diabetic patientsDiabetic Medicine, 2004
- Carotid Atherosclerosis is Correlated with Extent and Severity of Coronary Artery Disease Evaluated by Myocardial Perfusion ScintigraphyAngiology, 2004
- Stent-Induced Expression and Activation of the Leukocyte Integrin Mac-1 Is Associated With Neointimal Thickening and RestenosisCirculation, 2003
- Oxidative DNA Damage is Induced by Chronic Cigarette Smoking, but Repaired by AbstentionJournal of Health Science, 2003
- Insulin resistance affects endothelium-dependent acetylcholine-induced coronary artery responseEuropean Heart Journal, 2000
- Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathyAmerican Heart Journal, 1994
- Elevation of C-reactive protein in “active” coronary artery diseaseThe American Journal of Cardiology, 1990
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986
- Effects of intracoronary injection of acetylcholine on coronary arterial diameterThe American Journal of Cardiology, 1986